In response to a comment concerning dogma in the field of MS, I am going to publish a series of posts that are designed to "challenge the dogma".
Dogma: persistent demyelination is a pathological features of non-relapsing progressive MS, i.e. secondary and primary progressive MS.
Question for Dr K: What is the evidence that there a sufficient number of demyelinated axons in non-relapsing progressive MS for remyelination therapeutic strategies to work?